NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 86 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | -65.3% | 22,500 | -10.4% | 0.00% | – |
| Q4 2021 | $121,000 | -36.6% | 25,100 | -4.9% | 0.00% | – |
| Q3 2021 | $191,000 | -21.7% | 26,400 | 0.0% | 0.00% | – |
| Q2 2021 | $244,000 | -10.6% | 26,400 | +18.9% | 0.00% | – |
| Q1 2021 | $273,000 | -20.9% | 22,200 | -9.4% | 0.00% | – |
| Q4 2020 | $345,000 | +17.3% | 24,500 | 0.0% | 0.00% | – |
| Q3 2020 | $294,000 | -6.4% | 24,500 | +29.6% | 0.00% | – |
| Q2 2020 | $314,000 | – | 18,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |